Cabergoline: A Tracking Guide for a Prolactin-Lowering Dopamine Agonist

Cabergoline is a long-acting dopamine D2 receptor agonist. Medically it treats conditions of excess prolactin (hyperprolactinemia) and prolactin-secreting pituitary tumors. In performance and physique contexts it is used to lower prolactin that has been raised by 19-nortestosterone compounds (nandrolone, trenbolone), which is associated with "prolactin gyno," low libido, and a long refractory period between erections.

This is an educational tracking guide, not medical advice or a recommendation. Cabergoline is prescription-only and carries a cardiac risk that makes casual use a poor idea.

What it does

• Mimics dopamine at D2 receptors on the pituitary, which suppresses prolactin release
• Lower prolactin can improve libido, shorten the refractory period, and reduce prolactin-driven breast tissue changes
• Because it is a dopamine agonist, it can also affect mood, nausea, and blood pressure

Typical protocol shape

Cabergoline is oral and long-acting, so it is dosed only once or twice a week, in small fractional-milligram amounts described in research literature. People often titrate to the lowest dose that controls symptoms and prolactin. Specific numbers are informational only and belong with a physician.

What to track weekly

• Libido, refractory period, and erection quality - the symptoms you are actually treating
• Mood, since over-suppressing prolactin can flatten libido and mood rather than help them
• Nausea, dizziness, or lightheadedness on standing (orthostatic drops are common early)
• Nasal congestion and sleep

Bloodwork worth doing

• Serum prolactin - to confirm it is actually elevated before treating, and to avoid pushing it too low
• Consider an echocardiogram before and during longer-term use: chronic higher doses of ergot-derived dopamine agonists are linked to cardiac valve fibrosis (valvulopathy). This is the single most important safety point.

Realistic expectations

When prolactin is genuinely elevated, cabergoline usually corrects it and restores libido and sexual function within days to a few weeks. If your symptoms are not actually from high prolactin, it will not fix them - and driving prolactin below normal can cause the exact low-libido, low-mood state people are trying to escape.

Common mistakes

• Taking it "just in case" without ever measuring prolactin
• Over-suppressing prolactin, which causes low libido, anhedonia, and low mood
• Ignoring the valvulopathy risk and using chronic higher doses without any cardiac monitoring
• Standing up too fast early in use and fainting from an orthostatic blood-pressure drop

Safety notes

The serious concern with cabergoline is cardiac valve fibrosis at high chronic doses, a risk established in Parkinson's patients using large amounts. Even at lower doses it can cause nausea, orthostatic hypotension, mood changes, and, rarely, impulse-control problems typical of dopamine agonists. It is prescription-only and should be used at the lowest effective dose, guided by prolactin testing and with echocardiogram consideration for anyone using it long term.

Peptid AI is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.